The Lupus Research Alliance, in partnership with the Rheumatology Research Foundation, announced a $1.9 million commitment to fund early-career scientists and junior investigators through the Empowering Lupus Research Partnership. The initiative aims to strengthen the research workforce and accelerate breakthroughs in lupus and rheumatology.
The funding will support innovative research projects exploring understudied biological pathways, translational science, and emerging concepts tied to lupus, a chronic autoimmune disease that causes widespread inflammation and tissue damage. The 2026 cohort includes five selected researchers whose work will examine links between lupus and menopause, cardiovascular disease, immunometabolism, and aging.
The grants are administered through two programs managed by the Rheumatology Research Foundation: the Scientist Development Award, which provides up to $225,000 over three years, and the Investigator Award, which provides up to $500,000 over four years. Applications underwent a rigorous peer-review process to identify the most promising research advancing lupus understanding and treatment.
The initiative comes at a time when the scientific community faces uncertainty around federal research funding, creating potential risks for long-term innovation. By combining resources, the two organizations aim to provide stability and ensure continued progress in lupus research.
Lupus disproportionately affects women, who account for approximately 90% of diagnoses, and occurs at higher rates among African American, Hispanic, Asian, and Native American and Alaskan Native populations. The disease is also associated with increased risks of comorbid conditions such as heart disease, osteoporosis, and kidney disease. The partnership’s goal is to accelerate discoveries that improve patient outcomes and quality of care.
The 2026 award recipients include Mehmet Hocaoglu, MD; Tristram A.J. Ryan, PhD; John P. Huizar, MD; Daniel Panyard, PhD; and Kristen Young, DO, MEd, each representing diverse research and clinical settings.
The Lupus Research Alliance is the largest non-governmental funder of lupus research globally, while the Rheumatology Research Foundation is one of the largest private funders of rheumatology research and training programs in the United States.
KEY QUOTES:
“The research community is navigating a volatile federal funding climate that could have long-term effects on scientific progress. By pooling our resources, we can respond quickly to strengthen the research pipeline. Our hope is that this funding sparks breakthroughs that bring answers and comfort to people affected by lupus.”
Eryn Marchiolo, President Of The Rheumatology Research Foundation
“Behind every discovery are dedicated investigators who need dependable support. This collaborative investment ensures early-career researchers can continue driving forward the advancements that people living with lupus urgently need.”
Teodora Staeva, PhD, Chief Scientific Officer Of The Lupus Research Alliance
“The Empowering Lupus Research Partnership drives progress in rheumatology and lupus research, supports investigators, and offers hope to those affected by rheumatic disease.”
Eryn Marchiolo, President Of The Rheumatology Research Foundation
